Published in Drug Week, October 10th, 2003
"Isoniazid is an efficacious treatment for latent tuberculosis. Concerns remain, however, regarding hepatotoxicity associated with this medication. In addition, adherence may be suboptimal because at least six months of treatment is required," scientists in the United States report.
"We extracted information from our latent tuberculosis treatment database to determine adverse effects and treatment completion rates associated with the use of isoniazid at a county tuberculosis clinic," stated Philip A. Lobue and Kathleen S. Moser at the Centers for Disease Control and Prevention....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week